DRUG RECALL — HEALTHCARE, MENTAL HEALTH & AGING
Check the vial: one lot of glutathione injection has been recalled.
This is a one-lot, patient-level recall—not a warning about every glutathione product. Optimal Balance Pharmacy says the affected compounded injection was distributed directly to consumers in New York and 13 other states. Here is the exact match and what the recall says to do.
Match every detail
- Company: Optimal Balance Pharmacy.
- Product: Glutathione Injection 200 mg/mL, 30 mL multi-dose vial.
- Lot: LG342009076.
- Expiration: October 4, 2026.
Optimal Balance Pharmacy voluntarily recalled the lot after its testing identified elevated bacterial endotoxin. The company announced the patient-level recall on August 19, and the FDA published the announcement on August 20. The notice lists direct-to-consumer distribution in Arizona, Colorado, Florida, Illinois, Louisiana, Michigan, New York, Nevada, Oklahoma, Pennsylvania, Texas, Utah, Vermont and Washington. It does not identify individual recipients or locations, and The Rockland Edit has not confirmed a Rockland prescription, recipient or adverse event. Read the FDA-posted announcement and view the product photos ↗
If the lot and expiration match
- Stop using the product immediately and quarantine it, according to the recall.
- Contact Optimal Balance Pharmacy to arrange retrieval and proper disposition. Do not discard the vial before receiving those instructions.
- Contact the prescribing physician if any symptom or problem may be related to using the product.
The announcement says patients and prescribers will receive a full refund for recalled product if they have not already been reimbursed.
Why the company recalled it
The announcement says injectable products with elevated endotoxin levels have a reasonable probability of causing significant medical events, including fever, low blood pressure, inflammatory reactions, anaphylactic shock and death. Optimal Balance Pharmacy says it has received reports of fever, chills, severe headache, nausea, vomiting, pain and symptoms consistent with an allergic reaction. The notice does not say that every reported event was independently confirmed as caused by this lot.
Questions and adverse-event reports
Optimal Balance Pharmacy lists 281-919-2964, Monday through Friday from 9 a.m. to 5 p.m. Central Time, for recall questions and retrieval arrangements. Patients and healthcare professionals may also report adverse reactions or product-quality problems through the FDA’s MedWatch program ↗.
The useful version is narrow: match Optimal Balance Pharmacy, the product and vial size, lot LG342009076, and the October 4 expiration. If all of it matches, stop using and quarantine the vial, then contact the pharmacy and the prescriber as the recall directs.
Source: FDA-posted Optimal Balance Pharmacy company announcement dated August 19 and published August 20, 2026. FDA page, product identifiers, patient instructions, contact information and recall status checked August 30, 2026, at 10:57 p.m. EDT. FDA posts company recall announcements as a public service and does not endorse the product or company. This service guide is not individualized medical advice.